TheFly.com
Start Free Trial
<
Back to all Breaking News
PTGX
8/1/2019 17:08pm
4
Street Research Stories
chevron_right
Protagonist Therapeutics: PN-943 was 'safe and well tolerated' in Phase 1 study
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
Join Now
Learn More
Already have an account?
Sign In Here
Subscription Rates
dynamic_feed
Breaking News
search
Search
menu
Menu
